References
- A.C.GuytonBlood pressure control-special role of the kidneys and body fluidsScience252199118131816
- F.PaillardD.ChanselE.BrandA.BenetosF.ThomasS.CzekalsliGenotype-phenotype relationships for the renin-angiotensin–aldosterone system in a normal populationHypertension341999423429
- R.PardoS.MalagaE.CotoRenin-angiotensin system polymorphisms and renal scarringPediatr Nephrol182003110114
- Y.T.LeeH.C.ChiuC.T.HuangH-.M.SuC-.L.WangT.H.LinThe A1166C polymorphism of angiotensin II type 1 receptor as a predictor of renal function decline over 4 years follow up in an apparently healthy Chinese populationClin Nephrol722009457467
- M.ZsomT.FülöpL.ZsomA.BarathZ.MarotiE.EndreffyGenetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patientsHemodial Int152011501508
- M.RosenbergL.SmithR.Correa- RotterT.HostetterThe paradox of the renin-angiotensin system in chronic renal diseaseKidney Int451994403410
- K.GriffinA.BidaniHypertensive renal damage: insights from animal models and clinical relevanceCurr Hypertens Res62004145153
- A.MondryM.LohP.LiuA.ZhuM.NagetPolymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: supervising new finding and meta-analysis of dataBMC Nephrol62005110
- F.LocatelliD.MarcelliM.ComelliD.AlbertiG.GrazianiG.BucciantiProteinuria and blood pressure as causal components of progression to end-stage renal failure: Northern Italian Cooperative Study GroupNephrol Dial Transplantat111996461467
- B.FreedmanD.BowdenThe role of genetic factors in the development of end-stage renal diseaseCurr Opin Nephrol Hypertens41995230234
- Y.NakauchiT.SuehiroM.YamamotoN.YasuokaK.AriiY.KumonSignificance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart diseaseAtherosclerosis1251996161169
- M.ElshamaaS.SabryH.BazaraaH.KouraE.ElghorouryN.KantoushGenetic polymorphism of ACE and the angiotensin II type 1 receptor genes in children with chronic kidney diseaseJ Inflammat820112030
- R.PontremoliM.RaveraF.ViazziC.NicolellaV.BerrutiG.LeoniciniGenetic polymorphism of the renin-angiotensin system and organ damage in essential hypertensionKidney Int572000561569
- J.WangL.XueP.HaoAngiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysisJ Renin Angiotensin Aldosterone Syst11201019
- A.BonnardeauxE.DaviesX.JeunemaitreI.FéryA.CharruE.ClauserAngiotensin II type 1 receptor gene polymorphisms in human essential hypertensionHypertension2419946369
- B.AgachanT.IsbirH.YilmazE.AkogluAngiotensin converting enzyme I/D, angiotensinogen T174 M-M235 T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patientsExp Mol Med352003545549
- S.GardierM.VincetP.LantelmeM-.O.RialG.BriccaH.MilonA1166C polymorphism of angiotensin II type 1 receptor blood pressure and arterial stiffness in hypertensionJ Hypertens22200421352142
- A.LabierreM.ArceJ.LopezG.CiuffoAngiotensin II type 1 receptor A1166C polymorphism and essential hypertension in San LuisBiocell302006447455
- W.NiuY.QiAssociation of angiotensin II type 1 receptor gene+ 1166A> C polymorphism with hypertension risk: evidence of a meta-analysis of 16474 subjectsHypertens Res33201011371143
- M.BuraczynskaP.KsiazekW.ZaluskaD.SpasiewiczT.NowickaA.KsiazekAngiotensin II type 1 receptor gene polymorphism in end-stage renal diseaseNephron9220025155
- E.CollB.CamposD.González-NünezA.BoteyE.PochAssociation between the A1166C polymorphism of the angiotensin II type 1 receptor and progression of chronic renal insufficiencyJ Nephrol162003357364
- B.RaizadaB.SkipperW.LuoL.GarzaC.HinesA.HarfordRenin-angiotensin polymorphism and QTc interval prolongation in end-stage renal diseaseKidney Int68200511861189
- B.AkmanC.TarhanS.SezerF.ÖzdemirRenin-angiotensin system polymorphism: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patientsRenal Failure312009196200
- G.MitchellL.MoyéE.BraunwaldJ.RouleauB.BernsteinE.GeltmanSphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular functionCirculation96199742544260
- A.Romero- CorralV.SomersJ.Sierra- JohnsonR.ThomasM.ClavellJ.KorinekAccuracy of body mass index in diagnosing obesity in the adult general populationInt J Obes (Lond)322008959966
- S.ShamsS.VahedF.SoltanzadV.KafilA.BarzegariS.AtashpazHighly effective DNA extraction method from fresh, frozen, dried and clotted blood samplesBio Impacts12011183187
- J.SambrookD.RussellDetection of DNA in agarose gel. The condensed protocols from molecular cloning: a laboratory manual2006Cold Spring Harbor Laboratory PressNY pp. 250–9
- P.DesjardinsD.ConklinNano drop microvolume quantitation of nucleic acidsJ Vis Exp2220102565
- B.PuriSPSS in practice: an illustrated guide2nd ed.2002ArnoldLondon (New York)
- G.HardyMendlian proportions in a mixed populationScience2819084950
- M.ZivkovicA.StankovicD.AlavanticAT1 receptor A1166C and AT2 receptor-1332 A/G gene polymorphism: efficient genotyping by single-tube PCRJ Clin Lab Anal1920058486
- W.FarragM.EidS.El- ShazlyM.AbdallahAngiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertensionMol Cell Biochem35120111318
- E.LovatiA.RichardB.M.FreyF.J.FreyP.FerrariGenetic polymorphism of the renin-angiotensin–aldosterone system in end-stage renal diseaseKidney Int6020014654
- M.BuraczynskaP.KsiazekA.DropW.ZaluskaD.SpasiewiczA.KsiazekGenetic polymorphism of the renin-angiotensin system in end-stage renal diseaseNephrol Dial Transplant212006979983
- B.FabrisM.BortolenttoR.CandidoGenetic polymorphism of the renin-angiotensin–aldosterone system and renal insufficiency in essential hypertensionJ Hypertens232005309316
- M.LajemiC.LabatS.GautierP.LacolleyM.SafarR.AsmaAngiotensin II type 1 receptor 153A/G and 1166 A/C gene polymorphisms and increased aortic stiffness with age in hypertensive subjectsJ Hypertens192001407413
- L.HindorftS.HeckbertR.TracyZ.TangB.PsatyK.EdwardsAngiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity and cardiovascular eventsAm J Hypertens15200210501056
- S.SchmidtJ.BeigeM.Walla- FriedelM.MichelA.ShamaA.RitzPolymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertensionJ Hypertens15199713851388
- S.TakamiT.KatsuyaH.RagukiAngiotensin II type 1 receptor gene polymorphism is associated with increased left ventricular mass but not with hypertensionAm J Hypertens111998316321
- X.ZhangJ.ErdmannV.Regitz-ZagrosekS.KurzingerH.HenseH.SchunkertEvaluation of three polymorphism in the promoter region of the angiotensin II type 1 receptor geneJ Hypertens182000267272
- Y.LiuC.ZhomaG.ShanC.CuiS.HouW.QinA1166C polymorphism of angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populationHypertens Res252002515521
- W.NiuH.ZhaoL.ZhouX.DaiD.WangJ.CaoInteracting effect of genetic variants of angiotensin II type 1 receptor on susceptibility to essential hypertension in Northern Han ChineseJ Hum Hypertens2320096871
- A.StankovicM.ZivkovicT.DjuricD.AlavanticAngiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian populationClin Chim Acta3272003181185
- A.MoulD.ShohamK.NorthAngiotensin II type 1 receptor polymorphism and susceptibility to hypertension: a Hu GF reviewGenet Med102008560574
- M.WeirEffects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther29200718031824
- H.HeerspinkT.NinomiyaS.ZoungasD.de ZeewuD.GrobbeeM.JardineEffect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomized controlled trialsLanced373200910091015
- J.K.InrigAntihypertensive agents in hemodialysis patients: a current perspectiveSemin Dial232010290297
- S.EfratiR.ZaidensteinV.DishyI.BeberashviliM.SharistA.AverbukhACE inhibitors and survival of hemodialysis patientsAm J Kidney Dis40200210231029
- C.BögerA.GötzB.KrügerM.HöstG.SchmitzJ.RieggerEffect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patientsEur J Med Res102005161168